Measure to increase FDA funds through new company fees goes to Obama

News | 27 June 2012

• Print This

Legislation heading for the president's signature would underwrite drug and medical-device reviews, for the first time including generics, and fast-track some approvals.

Click on the link to read the full article at Washington Post
(This link will open in a new window)